Training future scientists in gastrointestinal cancers
Official title: Multidisciplinary Training in Gastrointestinal Cancers
Funded at Columbia University Health Sciences · NIH-10769254 · Data updated 2026-11-12
This study is all about training new scientists to better understand and find ways to treat GI cancers, like those affecting the stomach and pancreas, so they can help improve care for patients like you.
Quick facts
| Grant type | Training grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2024 |
| Award (this year) | $193,144 |
| NIH project number | 1T32CA285274-01 |
| Project ID | NIH-10769254 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation or benefit from this research include individuals interested in pursuing a career in cancer research, particularly those focused on gastrointestinal malignancies.
✕Less likely to help
Patients who are not pursuing a career in research or who do not have a specific interest in gastrointestinal cancers may not receive direct benefits from this research.
What this research studies
This research focuses on training the next generation of scientists to investigate gastrointestinal (GI) cancers, which include malignancies of the esophagus, stomach, pancreas, and more. The program is based at Columbia University Irving Medical Center and involves a multidisciplinary approach, integrating basic science, clinical research, and bioinformatics. By addressing the biological mechanisms and disparities in treatment outcomes, the training aims to equip researchers with the skills needed to advance GI cancer research and improve patient care. Participants will engage with a diverse group of mentors and gain hands-on experience in various research methodologies.
Why it matters
Potential benefit: If successful, this research could lead to improved understanding and treatment of gastrointestinal cancers, ultimately enhancing patient outcomes.
How similar studies have gone: Other research initiatives have successfully trained scientists in cancer research, indicating that this multidisciplinary approach is effective and valuable.
Where this research is happening
-
Columbia University Health Sciences
New York, United States Active
Researchers
- Principal investigator: Abrams, Julian — Columbia University Health Sciences
- Study coordinator: Abrams, Julian
Related research
Other NIH-funded projects on the same topics.
-
Bacterial biosensors to detect and help prevent GI cancers
A team is building living bacterial sensors that could detect colorectal and pancreatic tumors inside the gut and give a clear diagnostic signal.
-
Gastrointestinal cancers: how stem cells and their environment shape cancer growth
A research project at Columbia University Health Sciences studies how stomach, esophagus, and other GI cancers start and evolve by looking at stem cells, nerve signals, and the surrounding tissue.
-
Bacterial biosensors to help detect GI cancers early
A living bacterial sensor is being developed to spot colorectal and pancreatic cancers early inside the GI tract and give a readable diagnostic output.
-
DPYD Genetic Testing in Community Cancer Care to Prevent Fluoropyrimidine Toxicity
A community-based study will test whether offering DPYD genetic testing before chemotherapy with FP drugs reduces severe side effects and hospitalizations for people with GI cancers.
-
Cell signaling and gene regulation in liver and gastrointestinal cancers
Researchers are looking at how signaling proteins and gene-regulating enzymes like SIRT6 interact to explain why fatty liver disease can turn into liver cancer.
-
Understanding and Improving Chemoradiation Response in Esophagogastric and Pancreatic Cancer
This grant aims to learn why esophagogastric and pancreatic cancers resist standard chemoradiation and to use that knowledge to guide better, biomarker-driven treatments.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.